Does central nervous system toxicity occur in transplant patients with hypocholesterolemia receiving cyclosporine?

J Heart Transplant. 1989 May-Jun;8(3):221-4.

Abstract

A syndrome of severe central nervous system toxicity (confusion, cortical blindness, quadriplegia, seizures, and coma) associated with cyclosporine therapy and a low serum cholesterol level in patients with liver transplants has been described. We present a case history of a patient who demonstrated several similar features after heart-lung transplantation. Possible cyclosporine neurotoxicity should be considered in any patients with hypocholesterolemia receiving this drug.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • Central Nervous System Diseases / chemically induced*
  • Cholesterol / blood*
  • Cyclosporins / adverse effects*
  • Cyclosporins / therapeutic use
  • Female
  • Heart Transplantation*
  • Humans
  • Lung Transplantation*
  • Postoperative Complications / etiology

Substances

  • Antilymphocyte Serum
  • Cyclosporins
  • Cholesterol
  • Azathioprine